Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Omnix Biopharmaceuticals (OMRI)

PAST TOP PICK
(A Top Pick Nov 20/06. Up 30%.) Missed a quarter and there were competitive threats so he got out and missed the upswing.
TOP PICK
Using plasma to stop bleeding in the surgical applications. 200% growth. Sells at about 20 X earnings. Management owns a big chunk. Just reported stellar numbers. Will ultimately get taken over.
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Omnix Biopharmaceuticals (OMRI) Frequently Asked Questions

What is Omnix Biopharmaceuticals stock symbol?

Omnix Biopharmaceuticals is a OTC stock, trading under the symbol OMRI (previously OMRI-Q on Stockchase) on the undefined (undefined). It is usually referred to as or OMRI

Is Omnix Biopharmaceuticals a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on OMRI (previously OMRI-Q on Stockchase) on Stockchase. Read the latest expert commentary for Omnix Biopharmaceuticals.

Is Omnix Biopharmaceuticals a good investment or a top pick?

Omnix Biopharmaceuticals was recommended as a Top Pick by Peter Hodson on 2006-11-20. Read the latest stock experts ratings for Omnix Biopharmaceuticals.

Why is Omnix Biopharmaceuticals stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Omnix Biopharmaceuticals.

Is Omnix Biopharmaceuticals worth watching?

Omnix Biopharmaceuticals is covered by Stockchase experts and is worth watching.